Value of 18FDG PET-CT in detecting the metastatic mediastinal lymph node in non-small cell lung cancer

( views:, downloads: )
LI Wan-long()
YU Jin-ming()
FAN Ting-yong()
FU Zheng()
Liu Xi-Bin()
ZHONG Wei-xia()
ZHANG Li-min()
Journal Title:
Volume 14, Issue 03, 2005
Key Word:


  • [1]Graeter TP, Hellwig D, Hoffmann K, et al. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg, 2003,75: 231-235.
  • [2]Gupta NC, Tamim WJ, Graeber GG. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest,2001,120: 521-527.
  • [3]Roman MR, Rossleigh MA, Angelides S, et al. Staging and managing lung tumor using F-18FDG coincidence detection. Clin Nucl Med, 2001,26: 383-388.
  • [4]Townsend DW, Beyer TA. Combined PET/CT scanner: the path to true image fusion. Br J Radiol, 2002,75: S24-30.
  • [5]Nakamoto Y, Osman M, Cohade C, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl,2002,43:1137-1143.
  • [6]Nishioka T, Shiga T, Shirato H, et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas, Int J Radiat Oncol Biol Phys, 2002, 53:1051-1057.
  • [7]Fritscher-Ravens A, Bohuslavizki KH, Brandt L, et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest, 2003,123: 442-451.
  • [8]Kernstine KH, Mclaughlin KA, Menda Y, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg,2002,73: 394-401.
  • [9]Tahara RW, Lackner RP. Is there a role for mediastinoscopy in patients with peripheral T1 lung cancers? Am J Surg,2000,180:488-491.
  • [10]Jeffrey D. Bradley, Sasha Wahab, et al. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys, 2003,56: 342-347.
  • [11]Imdahl A, Jenkner S, Brink I, et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.Eur J Cardiothorac Surg,2001,20: 324-329.
  • [12]于金明.十一世纪的放射肿瘤学. 中华肿瘤杂志,2002,24: 521-525.
  • [13]Eschmann SM, Friedel G, Paulsen F, et al. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radiochemotherapy. Eur J Nucl Med Mol Imaging,2002,29: 804-808.
  • [14]von Haag DW, Follette DM, Roberts PF, et al. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer. J Surg Res,2002,103:160-164.
  • [15]Gupta NC, Graeber GM, Bishop HA, et al. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small ( 《 1 cm), intermediate ( 1 to 3 cm), and large ( 》 3 cm) lymph node lesions. Chest,2000, 117:773-778.
  • [16]D' Amico TA, Wong TZ, Harpole DH, et al. Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. Ann Thorac Surg,2002,74:160-163.
  • [17]Albes JM, Dohmen BM, Schott U, et al. Value of positron emission tomography for lung cancer staging. Eur J Surg Oncol,2002,28: 55-62.
  • [18]Magnani P, Carretta A, Rizzo G, et al. FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg, 1999,40: 741-748.
  • [19]Liengswangwong V, Bonner JA. Point, the potential importance of elective nedal irradiation in the treatment of non-small cell lung cancer.Semin Radiat Oncol,2000,10:308-314.
  • [20]Williams TE, Thomas CR, Turrisi AT. Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol,2000, 10:315-323.
  • [21]Rosenzweig KE, Sim SE, Mychalczak B, et al,Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys, 2001,50:681-685.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615